Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AMJ Global Technology (OTCPK:AMJT) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
AMJ Global Technology's Enterprise Value for the quarter that ended in Aug. 2025 was $137.35 Mil.
AMJ Global Technology's EBIT for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, AMJ Global Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AMJ Global Technology EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, AMJ Global Technology's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where AMJ Global Technology's EV-to-EBIT falls into.
AMJ Global Technology's current Enterprise Value is $141.45 Mil.
AMJ Global Technology's EBIT for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMJ Global Technology (AMJT) has a EV-to-EBIT of -120.18 as of Jul. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on AMJ Global Technology and its competitors.
Is AMJ Global Technology's EV-to-EBIT too high?
AMJ Global Technology's current EV-to-EBIT is -120.18. Overall, AMJ Global Technology has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does AMJ Global Technology's EV-to-EBIT compare to CCLD and LFMD?
AMJ Global Technology's EV-to-EBIT of -120.18 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBIT is 15.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on AMJ Global Technology and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AMJ Global Technology's current EV-to-EBIT is -120.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMJ Global Technology stock overvalued right now?
AMJ Global Technology (AMJT) has a current EV-to-EBIT of -120.18. The current EV-to-EBIT is -120.18. AMJ Global Technology's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For AMJ Global Technology (AMJT), the current EV-to-EBIT is -120.18 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AMJ Global Technology is a USA-based company which is focusing on the intersection of technology and wholistic technology-based health treatments, with the intention to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer's. The Company is currently evaluating operations in the wholistic health industry. The Company has not generated any revenue.
32GF Score
Get the complete analysis for AMJT
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMJT has been successfully added to your 
